Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI
· Real-Time Price · USD
3.88
-0.13 (-3.24%)
At close: Aug 15, 2025, 3:59 PM
3.88
-0.13%
After-hours: Aug 15, 2025, 07:51 PM EDT
Atai Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -26.46M | -38.99M | -27.03M | -57.31M | -26.71M | -18.29M | 43.37M | -33.77M | -34.35M | -46.65M | -35.7M | -37.51M | -37.56M | -93.27M | -31.64M | -53.37M | 4.04M |
Depreciation & Amortization | 216K | 225K | 83K | 82K | 83K | 101K | 74K | 79K | 65K | 53K | 36K | 19K | 60K | 29K | -7K | 19K | 6K |
Stock-Based Compensation | 3.35M | 8.4M | 5.05M | 6.28M | 5.76M | 7.3M | 8.25M | 8.76M | 8.66M | 12.14M | 10.52M | 9.51M | 10.21M | 13.4M | 12.24M | 37.51M | 212K |
Other Working Capital | n/a | -1.9M | 1.1M | 2.91M | -4.27M | 3.56M | -1.35M | 1.9M | -2.48M | -3.45M | -121K | 2.83M | 433K | -3.69M | -811K | 21.7M | -27.1M |
Other Non-Cash Items | n/a | 10.1M | 4.87M | 31.83M | 9.98M | -4.28M | 416K | 81K | 856K | 2.92M | -2.93M | 3.92M | 4.76M | 6.18M | -466K | 9.5M | 838K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -8.5M | -70.89M | 1.41M | n/a | 5.07M | n/a | n/a | n/a | 52.87M | -3.37M | -12.03M | 1.66M |
Change in Working Capital | n/a | -4.04M | -3.03M | 2.89M | -5.01M | 2.57M | 341K | 831K | 3.66M | -4.04M | 34K | 2.13M | -1.45M | 278K | -4.86M | 20.27M | -23.29M |
Operating Cash Flow | -17.84M | -24.3M | -19.34M | -16.23M | -22.57M | -21.1M | -18.43M | -22.61M | -21.11M | -30.5M | -28.05M | -21.93M | -23.99M | -20.51M | -28.11M | 1.9M | -16.52M |
Capital Expenditures | n/a | -89K | -1K | n/a | -5K | -10.04K | -2K | -128K | -443K | -223K | -529K | -216K | -56K | -357K | -318K | -278K | -175K |
Cash Acquisitions | n/a | 359K | n/a | n/a | n/a | 37K | 2K | 157K | n/a | 171.12M | -94.06M | n/a | -211.68M | -47.58M | -3K | -4.89M | -468K |
Purchase of Investments | n/a | -5M | 96.92M | -65.56M | -31.36M | -5.32M | -138.15M | -39.62M | n/a | -52.5M | -27.48M | -18M | -211.68M | 1K | -214K | -22.68M | -762K |
Sales Maturities Of Investments | n/a | 11.29M | -55.66M | 84.26M | 43.84M | 7.01M | 93.65M | 17.74M | 19.46M | 132.78M | 94.06M | n/a | n/a | 2.42M | -495K | -155K | n/a |
Other Investing Acitivies | -11.01M | -83K | -3.83M | -2.4M | -1M | -1.9M | -1.98M | -157K | -3M | -171.12M | 94.06M | 76.98K | -3M | -3.12M | 416K | -301K | -2.32M |
Investing Cash Flow | -11.01M | 6.56M | 24.84M | 16.3M | 11.47M | -189.28K | -46.48M | -22M | 16.02M | 80.05M | 66.05M | -18.21M | -214.74M | -48.63M | -614K | -28.31M | -3.72M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15M | n/a | n/a | 1K | -1K | -1.58M | 3.17M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 60.17M | 154K | 4.89M | 326K | n/a | -8.48M | n/a | -101.48K | 206K | -1.25M | 4.78M | 1.79M | 132K | 1.72M | 3.88M | -6.17M | -1.04M |
Financial Cash Flow | 59.6M | 154K | 4.89M | 326K | n/a | -8.46M | -47.68 | -100K | 206K | -922K | 19.78M | 1.79M | 132K | 1.72M | 3.88M | 373.76M | 30.5M |
Net Cash Flow | 30.78M | -17.46M | 10.63M | 466K | -21.17M | -31.46M | -64.6M | -44.8M | -4.73M | 48.07M | 58.41M | -39.84M | -238.29M | -68.04M | -23.31M | 349.25M | 7.12M |
Free Cash Flow | -17.84M | -24.38M | -19.34M | -16.23M | -22.58M | -21.11M | -18.43M | -22.74M | -21.55M | -30.73M | -28.57M | -22.15M | -24.04M | -20.87M | -28.43M | 1.62M | -16.7M |